Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Joshua J Fenton
Clinicians Should Think Twice Before Prescribing DPP-4 Inhibitors for Diabetes
Evidence-Based Medicine
Medicine
Journals Should Lead the Way in Improving Medical Press Releases
Evidence-Based Medicine
Medicine
Related publications
Think Twice Before You Tell
Netherlands Heart Journal
Cardiovascular Medicine
Cardiology
Emerging DPP-4 Inhibitors: Focus on Linagliptin for Type 2 Diabetes
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Internal Medicine
Pharmacology
Dipeptidyl Peptidase 4 (Dpp-4) Inhibitors for the Treatment of Type 2 Diabetes Mellitus
Journal of thee Medical Sciences (Berkala Ilmu Kedokteran)
Use of DPP-4 Inhibitors in Type 2 Diabetes: Focus on Sitagliptin
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Internal Medicine
Pharmacology
Need for Streamlined Use of DPP-4 Inhibitors in the Treatment of Type 2 Diabetes
Cardiovascular Diabetology
Internal Medicine
Cardiology
Endocrinology
Cardiovascular Medicine
Metabolism
Diabetes
Diabetes Mellitus and DPP IV/CD26 Inhibitors
Medicina Fluminensis
Medicine
Sodium–glucose Co-Transporter 2 Inhibitors: Think Twice About Diabetic Ketoacidosis
Erratum To: DPP-4 Inhibitors in Diabetic Complications: Role of DPP-4 Beyond Glucose Control
Archives of Pharmacal Research
Organic Chemistry
Drug Discovery
Molecular Medicine
DPP-4/SGLT2 Inhibitor Combined Therapy for Type 2 Diabetes
Prescriber
Pharmacology